This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Schuchter, MD, FASCO , the Madlyn and Leonard Abramson Professor of Clinical Oncology and director of the Tara Miller Melanoma Center at Penn Medicine , is the 2023-2024 ASCO President, and the ASCO Annual Meeting program features more than 200 sessions complementing her Presidential Theme: "The Art and Science of Cancer Care: From Comfort to Cure."
Patients with less tau pathology on PET scans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Research suggests that the accumulation of these proteins is a continuous process that starts decades before the onset of symptoms.
Based on a novel clustering framework using sparse canonical correlation analysis (SCCA), the integrated approach was successful in identifying four subtypes of Alzheimer’s disease and the top genes associated with each, according to the authors of the study, “An SCCA-clustering framework for Alzheimer’s disease subtyping using tau PET and genomics.”
christine.book Mon, 06/26/2023 - 12:46 June 26, 2023 — PET imaging with 68Ga-FAPI offers a feasible, reliable, and reproducible method for evaluating disease activity in rheumatoid arthritis, according to new research presented at the 2023 Society of Nuclear Medicine and Molecular Imaging Annual Meeting.
A predictive model combining multiple ultrasonic parameters could discriminate between different liver diseases in a study published March 19 in Radiology. These findings are important for noninvasive assessment of the MAFLD disease process,” the Liu team wrote. The results have been promising when compared to liver biopsy.
milla1cf Tue, 09/26/2023 - 15:32 September 26, 2023 — In a study of more than 2,000 chest X-rays , radiologists outperformed AI in accurately identifying the presence and absence of three common lung diseases, according to a study published in Radiology , a journal of the Radiological Society of North America ( RSNA ).
Food and Drug Administration (FDA) has approved Eli Lilly's drug donanemab (Kisunla) for the treatment of early Alzheimer's disease, including mild cognitive impairment or mild dementia. According to clinical trials, amyloid PET scans showed that donanemab reduced amyloid plaques by up to 84% after 18 months of treatment.
one of the leading providers in healthcare radiology informatics, has today announced that the latest results from its AI-powered radiology screening and diagnostic programs will be presented at this year’s European Congress of Radiology ( ECR 2024 ) in Vienna, Austria, between February 28 – March 03.
The findings add to the growing evidence of the efficacy and safety of its FDA-approved GammaTile Therapy, and were presented during an Oct. 2 poster presentation at the American Society for Radiation Oncology's (ASTRO) 65th Annual Meeting, ASTRO 2023 , being held this week in San Diego, CA.
National Institutes of Health (NIH) has highlighted a study that shows cardiac PET scans can help identify people at risk for Parkinson’s disease and Lewy body dementia. Significantly, the research supports a “body first” progression model for the diseases, the researchers suggested. “We
The company will showcase booth exhibitions and present research abstracts at the event. During this conference, Heuron will be showcasing Heuron AgingCare Suite, an MRI-based diagnostic support solution for degenerative brain diseases, and Heuron StroCare Suite, a non-contrast CT -based comprehensive diagnostic support solution for stroke.
PET imaging with POSLUMA reveals clinical information crucial to decision-making for men with prostate cancer, and we are excited to share further information with the radiation oncology community at ASTRO 2023,” said David E. PET in Patients with Suspected Prostate Cancer Recurrence at PSA Levels Presenter: Ashesh B.
milla1cf Fri, 05/10/2024 - 08:10 May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting , fat-enlarged axillary nodes on screening mammograms can predict high cardiovascular disease (CVD) risk, Type 2 diabetes (T2DM), and hypertension (HTN). Rubino et al.
PET scans have revealed specific brain pathology that may drive sleep disturbances in Alzheimer’s disease patients, according to a study published February 8 in the Journal of the Neurological Sciences. Of these, 119 (43%) had normal cognition, 132 (24%) had mild cognitive impairment, and three (2%) had Alzheimer’s disease.
christine.book Tue, 06/20/2023 - 14:03 June 20, 2023 — Ascelia Pharma presented data from its Orviglance Hepatic Impairment study during the European Society of Gastrointestinal and Abdominal Radiology (ESGAR) 2023 annual meeting held June 14-16 in Valencia, Spain. So, we follow these patients; we see them many times,” said Kartalis.
a global leader in clinically proven AI -powered solutions that enable medical providers to accurately and reliably detect cancer earlier and improve patient outcomes, will highlight scientific presentations, including an award-winning poster at the European Congress of Radiology ( ECR ) annual meeting in Vienna, Austria, Feb 28 – March 3, 2024.
mtaschetta-millane Fri, 07/19/2024 - 09:25 July 19, 2024 — GE HealthCare announced it has entered into an agreement to acquire Intelligent Ultrasound Group PLC’s clinical artificial intelligence (AI) software business for total consideration of approximately $51 million.
milla1cf Tue, 06/11/2024 - 18:41 June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac amyloidosis, a condition referred to as the “Alzheimer’s disease of the heart.” This research was presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting.
Detecting breast arterial calcifications on routine mammograms could identify women at a higher risk of future cardiovascular disease (CVD), a study published March 13 in Clinical Imaging found. They categorized breast arterial calcifications as binary (present/absent) and semi-quantitatively (mild, moderate, severe).
The guideline emphasizes the need for a multidisciplinary team approach to guide treatment decisions for oligometastatic disease, a description for cancer that reaches a state in which the patient has a small number of metastases in addition to a primary tumor. The guideline is published in Practical Radiation Oncology.
Markers that indicate the presence of Parkinson's disease in patients on average seven years before clinicalpresentation have been identified by a UCL and Moorfields Eye Hospital research team.
Aitia is highlighting that data from its Alzheimer's Disease Digital Twins platform will be presented at the upcoming Clinical Trials on Alzheimer's Disease (CTAD), being held from October 24 to 27 in Boston.
PET/CT imaging with F-18 sodium fluoride (NaF) is emerging as a sensitive tool for detecting early atherosclerosis, according to a presentation at the recent Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. In this study, Patil and colleagues assessed its utility in patients at low to moderate risk for the disease.
Ultrasound contrast agents show promise for detecting and evaluating uterine disorders and prostate cancers, according to research presented at the annual Advances in Contrast Ultrasound meeting in Chicago. He recommended that sonographers be trained to place IVs and administer the ultrasound agent.
ChatGPT-4 consistently produces clinical vignettes that stereotype certain races, ethnicities, and genders, according to a study published in the January issue of The Lancet: Digital Health. Prompts included, for instance, the following: “Compose a brief presentation of a patient presenting with [CONDITION].
milla1cf Thu, 06/29/2023 - 21:10 June 29, 2023 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced highlights from early clinical and preclinical studies of 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1
PET brain scans show persistent brain inflammation in patients with multiple sclerosis (MS), despite being treated with high-efficacy disease-modifying therapies, according to a recent study by researchers in Boston. Image courtesy of Clinical Nuclear Medicine. The full article is available here.
We’re once again providing a modality-by-modality overview of select scientific presentations to serve as your guide to events at McCormick Place. In fact, it’s hard to find a scientific session without at least one AI-related presentation. Central Standard Time on November 27 as well as daily presentations from vendors.
Editor's note: As part of the celebration of AuntMinnie.com's upcoming 25th anniversary, we're presenting 25 for 25 -- a series featuring our most popular content for each of the last 25 years. Topping the list in 2020 was a story on how patients with COVID-19 may initially present with non-respiratory symptoms.
Organizing pneumonia can hide underlying lung cancers in up to 10% of cases, and repeat imaging in the form of PET/CT -- and additional biopsy -- should be considered in patients with high clinical suspicion of malignancy, researchers have reported. Kim discussed a case that demonstrated how additional biopsy proved necessary.
milla1cf Fri, 02/09/2024 - 09:17 February 9, 2024 — A novel PET imaging technique can noninvasively detect active inflammation in the body before clinical symptoms arise, according to research published in the February issue of The Journal of Nuclear Medicine. It is a complex autoimmune disease characterized by chronic inflammation.
At this year's RSNA meeting, attendees will have the opportunity to learn about MRI's research and clinical "edges" as presenters from around the world report on study findings across a range of topics. A combined MRI/ultrasound model improves breast disease detection Sunday, December 1 | 11:45 a.m.-12:15 12:15 p.m. |
PET scans typically used for diagnosing prostate cancer may have value in detecting inflammatory bowel disease (IBD), according to a case series published December 8 in Clinical and Experimental Gastroenterology. Image courtesy of Clinical and Experimental Gastroenterology. He was admitted to the hospital.
PMID: 34462252 Clinical Question: Does AVAPS NIPPV in patients with hypercapnic respiratory failure improve PaCO2 and pH values better than traditional BiPAP NIPPV? Balkan Med J 2021. AVAPS: 0.07 P = 0.015 PaCO2 Excretion in 1 st Hour BPAP S/T: 4.75 AVAPS: 10.20 AVAPS: 0.07 P = 0.015 PaCO2 Excretion in 1 st Hour BPAP S/T: 4.75 AVAPS: 10.20
Administration of the therapeutic dose took place as part of an ongoing Phase I/IIa theranostic clinical trial conducted by Clarity Pharmaceuticals to investigate the safety and efficacy of Cu-67 SARTATE in pediatric patients with high-risk neuroblastoma.
Many women with early-stage HR+HER2- breast cancer and a negative presurgical axillary ultrasound can skip sentinel lymph node biopsy, a study presented April 11 at the American Society of Breast Surgeons Annual Meeting in Orlando, FL, found. had grade 1 or 2 disease. However, Giannakou noted that median follow-up was shorter (26.3
Yet several presentations to be given at the meeting reminded us that issues concerning basic elements of x-ray technology remain highly important, as well as whether imaging access is equitable in the "real-world." Here, we’ve highlighted just a small sample of digital x-ray presentations scheduled for RSNA 2023. . | 2:00 p.m. |
The finding is from a study that showed greater brain metabolic decline in patients with the disease than those without over 3.8 years, noted corresponding author Kejal Kantarci, MD, of the Mayo Clinic in Rochester, MN, and colleagues. DLB is the second most common neurodegenerative dementia after Alzheimers disease.
Clinical Scenario: A 45-year-old woman with hypertension presents with a productive cough and fever. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. BMJ (Clinical research ed.). Her vitals are: HR 115, BP 120/80, Temp 102.8, O2 Sat 99% on RA, RR 18.
A recently developed PET radiotracer identified sources of pain in patients with complex regional pain syndrome (CRPS) and led to effective treatments, according to a study presented June 10 at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
We’re once again providing a modality-by-modality overview of select scientific presentations to serve as your guide to events at McCormick Place. Many other scientific presentations, scientific posters, educational courses and exhibits, and plenary sessions on AI topics also await attendees. Sunday, December 1 | 9:50 a.m.-10:00
tesla) is as clinically useful as conventional 1-tesla and 3-tesla systems for applications ranging from point-of-care MRI for critically ill patients to lumbar spine visualization. For more information on the presentations we're highlighting below and other abstracts, take a look at the RSNA 2023 meeting program. . | 1:10 p.m. |
We believe it further validates the clinical utility of POSLUMA in patients with newly diagnosed or recurrent prostate cancer, and can help expand patient access. FDA, as well as on the Phase 3 clinical trial results published recently in the Journal of Urology and European Urology. Chief Executive Officer of the Company. “We
A deep-learning AI model shows promise in helping clinicians assess cardiac sarcoidosis on PET scans, according to research presented on September 6 at the American Society of Nuclear Cardiology annual meeting in Austin, TX. In the absence of treatment, the disease can lead to irreversible fibrosis and sudden cardiac death.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content